FINOTTI, Alessia
 Distribuzione geografica
Continente #
NA - Nord America 9.927
EU - Europa 4.136
AS - Asia 2.936
SA - Sud America 44
OC - Oceania 27
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.097
Nazione #
US - Stati Uniti d'America 9.861
CN - Cina 1.505
IT - Italia 1.133
PL - Polonia 1.008
SG - Singapore 628
UA - Ucraina 514
DE - Germania 501
TR - Turchia 345
GB - Regno Unito 285
SE - Svezia 283
ID - Indonesia 176
FI - Finlandia 141
FR - Francia 95
HK - Hong Kong 78
CA - Canada 53
VN - Vietnam 47
IR - Iran 37
BR - Brasile 35
IN - India 35
BE - Belgio 32
CZ - Repubblica Ceca 25
RU - Federazione Russa 22
AU - Australia 21
GR - Grecia 19
NL - Olanda 16
RO - Romania 16
PK - Pakistan 13
EG - Egitto 11
JP - Giappone 11
LT - Lituania 10
MX - Messico 10
CH - Svizzera 9
KR - Corea 9
MY - Malesia 9
TW - Taiwan 7
ES - Italia 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
IE - Irlanda 5
LY - Libia 5
TH - Thailandia 5
TN - Tunisia 5
SA - Arabia Saudita 4
AR - Argentina 3
DM - Dominica 3
EC - Ecuador 3
IQ - Iraq 3
PH - Filippine 3
PT - Portogallo 3
BD - Bangladesh 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BT - Bhutan 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
KW - Kuwait 1
LI - Liechtenstein 1
MT - Malta 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 17.097
Città #
Woodbridge 1.127
Fairfield 1.122
Warsaw 1.005
Chandler 775
Ann Arbor 772
Ashburn 720
Houston 662
Jacksonville 652
Beijing 505
Singapore 486
Wilmington 466
Seattle 443
Ferrara 389
Cambridge 339
Nanjing 245
Izmir 225
Princeton 199
Jakarta 163
Addison 130
Boardman 128
Shanghai 126
Bremen 111
New York 109
Bologna 100
Redwood City 93
Milan 87
San Diego 86
Shenyang 81
Hong Kong 69
Los Angeles 61
Nanchang 61
Falls Church 58
Hebei 48
Munich 48
Dong Ket 47
Santa Clara 46
Dearborn 43
London 40
Changsha 38
Jiaxing 38
Jinan 33
Mountain View 33
Auburn Hills 30
Norwalk 30
Brussels 27
Zhengzhou 27
Guangzhou 25
San Jose 25
Tianjin 23
Rome 22
Des Moines 21
Washington 21
Kunming 19
Brno 18
Toronto 18
Ferrara di Monte Baldo 17
Ningbo 17
Verona 17
Helsinki 16
Parma 16
Hefei 15
Leawood 15
Hangzhou 14
Frankfurt am Main 12
Padova 12
Chicago 10
Fars 10
Indiana 10
Montréal 10
Napoli 10
Catania 9
Lanzhou 9
Orange 9
Ottawa 9
Tappahannock 9
Changchun 8
Redmond 8
Chengdu 7
Fuzhou 7
Kilburn 7
Leiden 7
San Mateo 7
Taizhou 7
Delhi 6
Foggia 6
Hounslow 6
Paris 6
Philadelphia 6
Preganziol 6
Sydney 6
Taipei 6
Wuhan 6
Yogyakarta 6
Augusta 5
Basel 5
Cattolica 5
Genoa 5
Guarda Veneta 5
Modena 5
Pars 5
Totale 12.714
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 306
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 291
A validated cellular biobank for β-thalassemia 277
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 255
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 228
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 209
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 199
A validated THALAMOSS cellular biobank for β-thalassemia 193
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis 179
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 176
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 172
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 172
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 170
Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices 156
SPR-based non-invasive prenatal testing for fetal sex determination 150
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 147
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 147
null 142
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 142
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 140
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 140
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 138
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 138
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 135
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: Hyper-activation of mTOR and STAT3 in leukocytes 131
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 129
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 129
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 127
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies 126
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 126
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 122
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 121
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 121
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 119
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 118
null 117
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 117
Regulation of IL-8 gene expression in gliomas by microRNAs 116
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 116
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 115
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 115
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 115
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 113
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 111
null 110
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 110
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 109
null 107
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 106
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development 106
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 106
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 106
AGENTI TRASFETTANTI PER ACIDI PEPTIDO-NUCLEICI 106
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 105
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 105
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 105
Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene 104
null 103
null 103
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 103
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 102
null 102
Involvement of miRNA in erythroid differentiation 101
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 101
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 101
Recent trends for novel options in experimental biological therapy of β-thalassemia 100
Efficient cell penetration and delivery of peptide nucleic acids by an argininocalix[4]arene 100
null 99
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 99
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 99
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 98
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 98
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 96
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 96
null 96
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA) 94
Recent trends in the gene therapy of β-thalassemia 90
Non-invasive Prenatal Testing Using Fetal DNA 90
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 89
Impiego di strategie di microRNA targeting combinate a trattamenti con composti di origine naturale ad attività antiproliferativa e pro-apoptotica: studio dell’effetto antitumorale in-vitro su modelli cellulari di carcinoma del colon-retto, di glioblastoma e di carcinoma mammario (NaturalMiR-Combo)” 89
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 87
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 86
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 85
null 85
Alteration of microRNA biological activity with peptide nucleic acid 84
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 84
Development of microRNA based protocols for detection of autologous blood transfusion in sport 84
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 83
Development and molecular characterization of transgenic mice for beta-thalassemia 82
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 82
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review) 79
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle 79
Invitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells 78
Expression of miR-93 and IL-8 During Pseudomonas aeruginosa Mediated Induction of Pro-Inflammatory Responses 77
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 77
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 76
In vitro evaluation of the biological activity of Lebanese medicinal plants extracts against herpes simplex virus type 1 76
SPR-based identification of microRNAs 76
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 75
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 75
Totale 12.050
Categoria #
all - tutte 85.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.215
Totale 89.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.070 0 0 0 0 217 313 260 286 322 395 186 91
2020/20213.158 164 143 140 195 198 295 283 313 139 480 514 294
2021/20222.113 226 179 129 93 138 107 141 96 95 170 182 557
2022/20231.959 230 191 41 240 322 224 125 179 205 16 106 80
2023/20241.494 84 182 63 42 188 251 121 86 24 28 75 350
2024/20251.150 181 152 495 289 33 0 0 0 0 0 0 0
Totale 17.676